India, Aug. 20 -- The Indian Institute of Technology Delhi (IIT Delhi) has inaugurated a state-of-the-art Biosafety Level 3 (BSL3) research facility to advance biomedical and clinical diagnostics research. The facility is part of the institute's Central Research Facility (CRF) and will support studies on diagnostic devices and therapeutics involving class-3 pathogens.

Located inside the campus, the facility is the first of its kind among leading educational institutions in India. It will be accessible to researchers, startups, and industries on a paid, assisted basis, promoting collaborations with medical institutes in the National Capital Region (NCR) and across India.

"This facility will bring scientists and engineers together to driv...